Remove 2023 Remove Coronary Artery Disease Remove Diabetes
article thumbnail

Abstract 4143220: Racial Differences in Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among US Veterans with Type 2 Diabetes and Coronary Artery Disease

Circulation

Background:Clinical trials have demonstrated that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) reduce cardiovascular (CV) risk in patients (pts) with type 2 diabetes (T2D) with or at high risk for CV disease. 1.04, P=0.3). 0.98, P=0.025).Conclusions:Among

article thumbnail

How To Reduce The Risk Of Heart Disease If You Have Insulin Resistance.

Dr. Paddy Barrett

Coronary artery disease is caused by the retention of a cholesterol particle in the artery wall. On the far end of that line is type two diabetes. On the far end of that line is type two diabetes. We also know that WHEN you get type 2 diabetes makes a huge difference. Let me be 100% clear, however.

article thumbnail

Abstract 262: National Trends of 90?day Readmission Rates and Etiologies among Diabetics following Transient Ischemic Attack

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence.

article thumbnail

7 Things You Can Do To Reduce Your Risk Even If You Already Have Heart Disease.

Dr. Paddy Barrett

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

article thumbnail

Have We Turned The Tide On Obesity?

Dr. Paddy Barrett

Between 2020 and 2023, the rates of obesity dropped by about 2% 2. Inflammation is a key driver of heart disease, specifically coronary artery disease. Sci Rep 13 , 20998 (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. 2023 Dec 14;389(24):2221-2232. Inflammation.

Obesity 60
article thumbnail

At What Age Should You Think About Assessing Your Risk For Heart Disease?

Dr. Paddy Barrett

But the goal in this instance is to die after a long and healthy life ‘ with ’ coronary artery disease rather than ‘ from ’ coronary artery disease. However, the chances of dying from heart disease are directly proportional to the amount of plaque in your coronary arteries.

article thumbnail

Abstract 215: A Sweet Indicator: HbA1C and Thrombectomy Outcomes in Hispanics

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThere is a higher prevalence of diabetes mellitus type 2 in Hispanics as compared to other ethnic groups in the United States. vs 72, p<0.001) compared to patients who did not have poorly controlled diabetes. or greater.